Back to search
FDAFDA · Food and drugs·Recall number F-0070-2020

OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2 FL OZ

Published October 30, 2019 · Recall initiated: September 25, 2019

Summary

FDA records food Class II recall F-0070-2020, published October 30, 2019 and initiated September 25, 2019. Recalling firm: Hall Global, LLC; Status: Terminated; Reported quantity: 1007 packages of 5 count caps; Lot: 10097902, 10186904, 10235905, and 10278906. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Yellow #6 is not declared on ingredient label. Label claim for B2 is incorrect (contains 5 mg not 10 mg as stated).

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hall Global, LLC
Distributor
Contract Manufacturer sends products to distribution centers owned by clients or direct to client company for distribution via internet to end product user.
Lot
10097902, 10186904, 10235905, and 10278906
Risk classification
Class II
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2 FL OZ recalled?

Yes. FDA published recall F-0070-2020 on October 30, 2019. Reported hazard: Yellow #6 is not declared on ingredient label. Label claim for B2 is incorrect (contains 5 mg not 10 mg as stated).

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit